Literature DB >> 10708426

Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.

S M Harrold1, S J Cook, R F Cook, K E Rushlow, C J Issel, R C Montelaro.   

Abstract

Equine infectious anemia virus (EIAV) infection of horses is characterized by recurring cycles of disease and viremia that typically progress to an inapparent infection in which clinical symptoms are absent as host immune responses maintain control of virus replication indefinitely. The dynamics of EIAV viremia and its association with disease cycles have been well characterized, but there has been to date no comprehensive quantitative analyses of the specific tissue sites of EIAV infection and replication in experimentally infected equids during acute disease episodes and during asymptomatic infections in long-term inapparent carriers. To characterize the in vivo site(s) of viral infection and replication, we developed a quantitative competitive PCR assay capable of detecting 10 copies of viral DNA and a quantitative competitive reverse transcription-PCR assay with a sensitivity of about 30 copies of viral singly spliced mRNA. Animals were experimentally infected with one of two reference viruses: the animal-passaged field isolate designated EIAV(Wyo) and the virulent cell-adapted strain designated EIAV(PV). Tissues and blood cells were isolated during the initial acute disease or from asymptomatic animals and analyzed for viral DNA and RNA levels by the respective quantitative assays. The results of these experiments demonstrated that the appearance of clinical symptoms in experimentally infected equids coincided with rapid widespread seeding of viral infection and replication in a variety of tissues. During acute disease, the predominant cellular site of viral infection and replication was the spleen, which typically accounted for over 90% of the cellular viral burden. In asymptomatic animals, viral DNA and RNA persisted in virtually all tissues tested, but at extremely low levels, a finding indicative of tight but incomplete immune control of EIAV replication. During all disease states, peripheral blood mononuclear cells (PBMC) were found to harbor less than 1% of the cellular viral burden. These quantitative studies demonstrate that tissues, rather than PBMC, constitute the predominant sites of virus replication during acute disease in infected equids and serve as resilient reservoirs of virus infection, even in the presence of highly effective immune responses that maintain a stringent control of virus replication in long-term inapparent carriers. Thus, these observations with EIAV, a predominantly macrophage-tropic lentivirus, highlight the role of tissues in sequestering lentiviral infections from host immune surveillance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708426      PMCID: PMC111810          DOI: 10.1128/jvi.74.7.3112-3121.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus.

Authors:  Y H Chong; S L Payne; C J Issel; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  Detection of proviral DNA in horse cells infected with equine infectious anemia virus.

Authors:  N R Rice; S Simek; O A Ryder; L Coggins
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

3.  Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages.

Authors:  H E Gendelman; O Narayan; S Kennedy-Stoskopf; P G Kennedy; Z Ghotbi; J E Clements; J Stanley; G Pezeshkpour
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

4.  Immunofluorescent localization of equine infectious anemia virus in tissue.

Authors:  T C McGuire; T B Crawford; J B Henson
Journal:  Am J Pathol       Date:  1971-02       Impact factor: 4.307

5.  Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs.

Authors:  Y Kono; K Hirasawa; Y Fukunaga; T Taniguchi
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1976

6.  Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections.

Authors:  S Rasty; B R Dhruva; R L Schiltz; D S Shih; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

7.  Viral DNA in horses infected with equine infectious anemia virus.

Authors:  N R Rice; A S Lequarre; J W Casey; S Lahn; R M Stephens; J Edwards
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Transmission of equine infectious anemia virus from horses without clinical signs of disease.

Authors:  C J Issel; W V Adams; L Meek; R Ochoa
Journal:  J Am Vet Med Assoc       Date:  1982-02-01       Impact factor: 1.936

9.  Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.

Authors:  L E Perryman; K I O'Rourke; T C McGuire
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow.

Authors:  H E Gendelman; O Narayan; S Molineaux; J E Clements; Z Ghotbi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more
  30 in total

1.  Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.

Authors:  S A Hammond; F Li; B M McKeon; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype.

Authors:  Prasith Baccam; Robert J Thompson; Yuxing Li; Wendy O Sparks; Michael Belshan; Karin S Dorman; Yvonne Wannemuehler; J Lindsay Oaks; James L Cornette; Susan Carpenter
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  Molecular detection, epidemiology, and genetic characterization of novel European field isolates of equine infectious anemia virus.

Authors:  Katia Cappelli; Stefano Capomaccio; Frank R Cook; Michela Felicetti; Maria Luisa Marenzoni; Giacomo Coppola; Andrea Verini-Supplizi; Mauro Coletti; Fabrizio Passamonti
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

4.  Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.

Authors:  Darrilyn G Fraser; Robert H Mealey; Travis C McGuire
Journal:  Immunogenetics       Date:  2003-08-27       Impact factor: 2.846

5.  Envelope variation as a primary determinant of lentiviral vaccine efficacy.

Authors:  Jodi K Craigo; Baoshan Zhang; Shannon Barnes; Tara L Tagmyer; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-10       Impact factor: 11.205

6.  Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.

Authors:  Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

7.  Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.

Authors:  Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

8.  Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.

Authors:  Xiue Han; Ping Zhang; Wei Yu; Wenhua Xiang; Xiaodong Li
Journal:  Virus Genes       Date:  2016-08-29       Impact factor: 2.332

9.  Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Authors:  Hal P Bogerd; Rebecca L Tallmadge; J Lindsay Oaks; Susan Carpenter; Bryan R Cullen
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

10.  An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.

Authors:  Jodi K Craigo; Shannon Barnes; Baoshan Zhang; Sheila J Cook; Laryssa Howe; Charles J Issel; Ronald C Montelaro
Journal:  Retrovirology       Date:  2009-10-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.